Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04155580
Title A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94143 United States Details
Smilow Cancer Hospital New Haven Connecticut 06510 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Northside Hospital - The Blood and Marrow Transplant Group of Georgia Atlanta Georgia 30342 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
Franciscan Health Indianapolis (Blood and Marrow Transplantation) Indianapolis Indiana 46237 United States Details
The University of Kansas Clinical Research Center Fairway Kansas 66205 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
New York University Langone Health New York New York 10016 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Vanderbilt - Ingram Cancer Center Nashville Tennessee 37232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field